Clinical Trial Update: Ofatumumab Cardiac Repolarization (QTc) Study in Fludarabine-Refractory Chronic Lymphocytic Leukemia Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the effect of ofatumumab on cardiac repolarization (QTc) in patients with fludarabine-refractory chronic lymphocytic leukemia has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Ofatumumab (ofatumumab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Leukaemia, Lymphocytic, Chronic | Phase 1 | Status: COMPLETED